Back to search
FDAFDA · Food and drugs·Recall number D-0393-2016

Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550

Published December 9, 2015 · Recall initiated: October 27, 2015

Summary

FDA records drug Class II recall D-0393-2016, published December 9, 2015 and initiated October 27, 2015. Recalling firm: Geritrex Corp; Status: Terminated; Reported quantity: 3,796 jars (8.4 oz) 3,204, (16.9 oz) 3,350; Lot: Lot #: a) 1201092, 1403053, 1210028, 1007059, 1112105, 1305044, 1303079, 1406098, 1407061, 1505037, 1412004 1408081, b) 1112105 & 1007036. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Geritrex Corp
Distributor
Nationwide
Lot
Lot #: a) 1201092, 1403053, 1210028, 1007059, 1112105, 1305044, 1303079, 1406098, 1407061, 1505037, 1412004 1408081, b) 1112105 & 1007036
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550 recalled?

Yes. FDA published recall D-0393-2016 on December 9, 2015. Reported hazard: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit